These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6768370)

  • 1. Sucralfate, a basic aluminum salt of sucrose sulfate. IV. Interaction with enzyme pepsin.
    Yoshida N; Terao N; Nagashima R
    Arzneimittelforschung; 1980; 30(1):78-80. PubMed ID: 6768370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sucralfate, a basic aluminum salt of sucrose sulfate. II. Inhibition of peptic hydrolysis as it results from sucrose sulfate interaction with protein substrate, serum albumins.
    Nagashima R; Yoshida N; Terao N
    Arzneimittelforschung; 1980; 30(1):73-6. PubMed ID: 6892774
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and characteristics of sucralfate.
    Nagashima R
    J Clin Gastroenterol; 1981; 3(Suppl 2):103-10. PubMed ID: 6798099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucralfate, a basic aluminum salt of sucrose sulfate. III. Inhibition of peptic hydrolysis of fibrinogen by sucrose sulfate.
    Terao N; Yoshida N; Nagashima R
    Arzneimittelforschung; 1980; 30(1):76-8. PubMed ID: 6892775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective binding of sucralfate to ulcer lesion. II. Experiments in rats with gastric ulcer receiving 14C-sucralfate or potassium 14C-sucrose sulfate.
    Nagashima R; Hinohara Y; Hirano T; Tohira Y; Kamiyama H
    Arzneimittelforschung; 1980; 30(1):84-8. PubMed ID: 6892777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate, a basic aluminum salt of sucrose sulfate. I. Behaviors in gastroduodenal pH.
    Nagashima R; Yoshida N
    Arzneimittelforschung; 1979; 29(11):1668-76. PubMed ID: 44471
    [No Abstract]   [Full Text] [Related]  

  • 8. Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.
    Borella LE; Seethaler K; Lippmann W
    Arzneimittelforschung; 1979; 29(5):793-8. PubMed ID: 387045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sucralfate protects the ulcer from acids and pepsin].
    von Bocko Polach U
    Med Klin; 1980 Oct; 75(21):764-7. PubMed ID: 6779100
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective binding of sucralfate to ulcer lesion. III. Experiments in rats with duodenal ulcer receiving 14C-sucralfate.
    Nagashima R; Hinohara Y; Hirano T
    Arzneimittelforschung; 1980; 30(1):88-91. PubMed ID: 6892778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sucralfate and its components on acid- and pepsin-induced damage to rat gastric epithelial cells.
    Furukawa O; Matsui H; Suzuki N
    Jpn J Pharmacol; 1997 Sep; 75(1):21-5. PubMed ID: 9334882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of peptic activity by sucralfate.
    Samloff IM; O'Dell C
    Am J Med; 1985 Aug; 79(2C):15-8. PubMed ID: 3929601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does basic aluminum sucrose sulfate affect blood coagulability?
    Mcgraw BF; Hesterlee EJ; Gitomer SL; Hollander DH
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):373-6. PubMed ID: 6893754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of sucralfate.
    Nagashima R
    J Clin Gastroenterol; 1981; 3(Suppl 2):117-27. PubMed ID: 6798100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sucralfate (Ulcogant). The mechanism of action of a cytoprotective agent].
    Steiner KF
    Fortschr Med; 1983 Dec; 101(47-48):2197-200concl. PubMed ID: 6423500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective binding of sucralfate to gastric ulcer in man.
    Nakazawa S; Nagashima R; Samloff IM
    Dig Dis Sci; 1981 Apr; 26(4):297-300. PubMed ID: 6894571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sucralfate: development of a new concept of anti-ulcer treatment. Review of its pharmacodynamic properties].
    Gorget C
    Rev Med Interne; 1985 Jun; 6(3):313-9. PubMed ID: 3901171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate prevents experimental peptic esophagitis in rabbits.
    Schweitzer EJ; Bass BL; Johnson LF; Harmon JW
    Gastroenterology; 1985 Mar; 88(3):611-9. PubMed ID: 3917956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective binding of sucralfate to ulcer lesion. I. Experiments in rats with acetic acid-induced gastric ulcer receiving unlabelled sucralfate.
    Nagashima R; Hirano T
    Arzneimittelforschung; 1980; 30(1):80-3. PubMed ID: 6892776
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH; Bighley LD; Iles RL
    J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.